[Update on legionellosis].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001706:Biopsy; D003937:Diagnosis, Differential; D018563:Disease Notification / Q000331:legislation & jurisprudence; D004197:Disease Reservoirs; D005455:Fluorescent Antibody Technique; D005602:France / Q000453:epidemiology; D006801:Humans; D017053:Infection Control / Q000379:methods; D007876:Legionellosis / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy / Q000635:transmission; D011159:Population Surveillance / Q000379:methods; D011322:Primary Prevention / Q000379:methods; D015980:Public Health Practice / Q000331:legislation & jurisprudence; D012307:Risk Factors; D012680:Sensitivity and Specificity; D014871:Water Microbiology
D000900:Anti-Bacterial Agents